During the past decade, Fundación Favaloro conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 11 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 9 clinical trials were completed. i.e. 90% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundación Favaloro" #1 sponsor was "Shire" with 5 trials, followed by "Amgen" with 3 trials sponsored, "Actelion" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundación Favaloro" #1 collaborator was "Eisai Inc." with 2 trials as a collaborator, "Actelion" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Ferrer Internacional S.A." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Fundación Favaloro" are "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Atrial Fibrillation" (2 trials), "Chronic Hepatitis" (2 trials) and "Hepatitis B" (2 trials). Many other conditions were trialed in "Fundación Favaloro" in a lesser frequency.

Most popular intervention types in "Fundación Favaloro" are "Drug" (21 trials), "Other" (4 trials), "Biological" (3 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ontamalimab" (4 trials), "5-FU" (2 trials), "Adefovir" (2 trials) and "Clevudine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fundación Favaloro" are 29 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fundación Favaloro". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Fundación Favaloro, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Fundación Favaloro, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Fundación Favaloro has several departments that took part in Clinical trials: "625-NOVAIN Neurociencias Group" - 2 trials, "Centro De Hepatologia" - 2 trials